A round of financing has brought in $12.3 million for Dune Medical Devices, which offers a radiofrequency spectroscopy system that enables real-time identification of microscopic residual cancer. The company intends to use the proceeds to create a standard of care using its MarginProbe System and support further development of its RF spectroscopy platform for other uses.
Dune Medical Devices obtains $12.3M in funding round
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.